UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
2 drugmakers to exclusively sell Merck’s diabetic treatment
Daewoong Bio and Hanall BioPharma have won exclusive rights to sell the gen...
by Lee Hye-seon
|
2017-03-27 17:58
라인
US FDA approves 1st treatment for rare skin cancer
The U.S Food and Drug Administration has granted approval to Bavencio (avel...
by Constance Williams
|
2017-03-27 16:29
라인
Family-controlled drugmaker draws attention
Ilsung Pharmaceutical drew popular attention last year playing a role in th...
by Nam Doo-hyun
|
2017-03-24 11:20
라인
Novartis heart medicine fails in clinical trial
Novartis' experimental drug for acute heart failure has failed to meet ...
by Marian Chu
|
2017-03-23 18:25
라인
Dongkook Pharmaceutical spins off contrast medium business
Dongkook Pharmaceutical is set to spin off its contrast medium business int...
by Lee Hye-seon
|
2017-03-23 11:52
라인
Tego Science to release new wrinkle cure this year
“TPX-105,” a wrinkle-improving cell therapy product developed by Tego Scien...
by Constance Williams
|
2017-03-22 16:36
라인
Green Cross enjoys sales of over ₩100 billion from flu vaccine
A Korean drugmaker is showing brilliant performances in the global flu vacc...
by Lee Hye-seon
|
2017-03-22 15:45
라인
Korean drug makers struggle in Central Asia
Kazakhstan and Uzbekistan rely heavily on imported medicines, but Korean dr...
by Nam Doo-hyun
|
2017-03-17 09:13
라인
Korea to make own version of 'Orange Book'
The Ministry of Food and Drug Safety will make the Korean version of “Orang...
by Lee Hye-seon
|
2017-03-16 16:27
라인
Boehringer's antidiabetic drug causes skin disease
Drug safety regulators are considering adding a warning that some diabetic ...
by Lee Hye-seon
|
2017-03-15 17:08
라인
'Botox war' erupts in Korea
As an increasing number of Korean pharmaceutical firms are developing Botul...
by Lee Hye-seon
|
2017-03-15 16:48
라인
Drug makers boast, with reason, of their ingredient names
Global organizations are increasingly adopting the ingredient names of new ...
by Lee Hye-seon
|
2017-03-14 11:19
라인
'Amgen Korea will win global recognition soon'
One and a half year have passed since Amgen, a role model for Korean bio an...
by Park Gi-taek
|
2017-03-13 18:30
라인
Hanmi Pharmaceutical Group shuffles top management
Hanmi Pharmaceutical appointed its two vice presidents, Woo Jong-su and Kwo...
by Marian Chu
|
2017-03-13 15:57
라인
Novartis’ leukemia treatment embroiled in efficacy dispute
“Tasigna” – the chronic myeloid leukemia therapy of Novartis which wo...
by Park Gi-taek and Lee Hye-seon
|
2017-03-13 09:21
라인
Ahngook's plan to enter US, European markets thwarted
Ahngook Pharm’s attempt to enter the U.S. and European markets with an inde...
by Lee Hye-seon
|
2017-03-09 14:23
라인
Why some pharms' operating profits plunged last year?
Among Korea’s major pharmaceutical companies, three – Hanmi Pharm, Do...
by Nam Doo-hyun
|
2017-03-08 18:18
라인
Expanded insurance benefits for new lymphoma remedy
Janssen Korea announced Tuesday that its treatment for mantle cell lymphoma...
by Constance Williams
|
2017-03-08 10:25
라인
Janssen Korea launches new narcotic painkiller
Janssen Korea released NUCYNTA ER, a new oral opioid drug for chronic pain,...
by Marian Chu
|
2017-03-06 17:15
라인
Pfizer Korea’s antismoke drug sales soar
The sales of Champix, Pfizer Korea’s antismoking drug, entered into the 40 ...
by Park Gi-taek
|
2017-03-06 12:30
-
이전
121
122
123
124
125
126
127
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top